カテゴリー： 世界, 医療/バイオ, QYResearch

家庭用インスリンデリバリー（投薬）装置の世界市場インサイト・予測（～2028年）

【英語タイトル】Global Home Insulin Delivery (Dosing) Devices Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX09543）・商品コード：QY22JLX09543
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：128
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥695,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,043,700見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,391,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、家庭用インスリンデリバリー（投薬）装置のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に家庭用インスリンデリバリー（投薬）装置の世界市場のxxx％を占める「インスリンペン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
家庭用インスリンデリバリー（投薬）装置の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの家庭用インスリンデリバリー（投薬）装置市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

家庭用インスリンデリバリー（投薬）装置のグローバル主要企業には、Tandem Diabetes Care、Biocon、Roche Holding AG、Insulet Corporation、B. Braun、BD、Eli Lilly and Company、Novo Nordisk、Sanofi、Wockhardt、Ypsomed Holding、Medtronic、Julphar、Beta Bionics、Copernicus、Dance Biopharm、Debiotech、MannKind、Owen Mumford、SOOIL、Valeritas、West Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

家庭用インスリンデリバリー（投薬）装置市場は、種類と用途によって区分されます。世界の家庭用インスリンデリバリー（投薬）装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
インスリンペン、インスリンポンプ、インスリン注射器、その他

【用途別セグメント】
病院薬局、オンライン薬局、小売薬局

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 家庭用インスリンデリバリー（投薬）装置製品概要
- 種類別市場（インスリンペン、インスリンポンプ、インスリン注射器、その他）
- 用途別市場（病院薬局、オンライン薬局、小売薬局）
- 調査の目的
・エグゼクティブサマリー
- 世界の家庭用インスリンデリバリー（投薬）装置販売量予測2017-2028
- 世界の家庭用インスリンデリバリー（投薬）装置売上予測2017-2028
- 家庭用インスリンデリバリー（投薬）装置の地域別販売量
- 家庭用インスリンデリバリー（投薬）装置の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別家庭用インスリンデリバリー（投薬）装置販売量
- 主要メーカー別家庭用インスリンデリバリー（投薬）装置売上
- 主要メーカー別家庭用インスリンデリバリー（投薬）装置価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（インスリンペン、インスリンポンプ、インスリン注射器、その他）
- 家庭用インスリンデリバリー（投薬）装置の種類別販売量
- 家庭用インスリンデリバリー（投薬）装置の種類別売上
- 家庭用インスリンデリバリー（投薬）装置の種類別価格
・用途別市場規模（病院薬局、オンライン薬局、小売薬局）
- 家庭用インスリンデリバリー（投薬）装置の用途別販売量
- 家庭用インスリンデリバリー（投薬）装置の用途別売上
- 家庭用インスリンデリバリー（投薬）装置の用途別価格
・北米市場
- 北米の家庭用インスリンデリバリー（投薬）装置市場規模（種類別、用途別）
- 主要国別の家庭用インスリンデリバリー（投薬）装置市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの家庭用インスリンデリバリー（投薬）装置市場規模（種類別、用途別）
- 主要国別の家庭用インスリンデリバリー（投薬）装置市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の家庭用インスリンデリバリー（投薬）装置市場規模（種類別、用途別）
- 主要国別の家庭用インスリンデリバリー（投薬）装置市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の家庭用インスリンデリバリー（投薬）装置市場規模（種類別、用途別）
- 主要国別の家庭用インスリンデリバリー（投薬）装置市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの家庭用インスリンデリバリー（投薬）装置市場規模（種類別、用途別）
- 主要国別の家庭用インスリンデリバリー（投薬）装置市場規模（トルコ、サウジアラビア）
・企業情報
Tandem Diabetes Care、Biocon、Roche Holding AG、Insulet Corporation、B. Braun、BD、Eli Lilly and Company、Novo Nordisk、Sanofi、Wockhardt、Ypsomed Holding、Medtronic、Julphar、Beta Bionics、Copernicus、Dance Biopharm、Debiotech、MannKind、Owen Mumford、SOOIL、Valeritas、West Pharma
・産業チェーン及び販売チャネル分析
- 家庭用インスリンデリバリー（投薬）装置の産業チェーン分析
- 家庭用インスリンデリバリー（投薬）装置の原材料
- 家庭用インスリンデリバリー（投薬）装置の生産プロセス
- 家庭用インスリンデリバリー（投薬）装置の販売及びマーケティング
- 家庭用インスリンデリバリー（投薬）装置の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 家庭用インスリンデリバリー（投薬）装置の産業動向
- 家庭用インスリンデリバリー（投薬）装置のマーケットドライバー
- 家庭用インスリンデリバリー（投薬）装置の課題
- 家庭用インスリンデリバリー（投薬）装置の阻害要因
・主な調査結果

Market Analysis and Insights: Global Home Insulin Delivery (Dosing) Devices Market
Due to the COVID-19 pandemic, the global Home Insulin Delivery (Dosing) Devices market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Insulin Pens accounting for % of the Home Insulin Delivery (Dosing) Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Home Insulin Delivery (Dosing) Devices market size is valued at US$ million in 2021, while the US and Europe Home Insulin Delivery (Dosing) Devices are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Home Insulin Delivery (Dosing) Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Home Insulin Delivery (Dosing) Devices include Tandem Diabetes Care, Biocon, Roche Holding AG, Insulet Corporation, B. Braun, BD, Eli Lilly and Company, Novo Nordisk and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Home Insulin Delivery (Dosing) Devices Scope and Segment
Home Insulin Delivery (Dosing) Devices market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Home Insulin Delivery (Dosing) Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Insulin Pens
Insulin Pumps
Insulin Syringes
Others
Segment by Application
Hospitals Pharmacy
Online Pharmacy
Retail Pharmacy
By Company
Tandem Diabetes Care
Biocon
Roche Holding AG
Insulet Corporation
B. Braun
BD
Eli Lilly and Company
Novo Nordisk
Sanofi
Wockhardt
Ypsomed Holding
Medtronic
Julphar
Beta Bionics
Copernicus
Dance Biopharm
Debiotech
MannKind
Owen Mumford
SOOIL
Valeritas
West Pharma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Home Insulin Delivery (Dosing) Devices Product Introduction
1.2 Market by Type
1.2.1 Global Home Insulin Delivery (Dosing) Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Insulin Pens
1.2.3 Insulin Pumps
1.2.4 Insulin Syringes
1.2.5 Others
1.3 Market by Application
1.3.1 Global Home Insulin Delivery (Dosing) Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Home Insulin Delivery (Dosing) Devices Sales Estimates and Forecasts 2017-2028
2.2 Global Home Insulin Delivery (Dosing) Devices Revenue Estimates and Forecasts 2017-2028
2.3 Global Home Insulin Delivery (Dosing) Devices Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Home Insulin Delivery (Dosing) Devices Sales by Region
2.4.1 Global Home Insulin Delivery (Dosing) Devices Sales by Region (2017-2022)
2.4.2 Global Sales Home Insulin Delivery (Dosing) Devices by Region (2023-2028)
2.5 Global Home Insulin Delivery (Dosing) Devices Revenue by Region
2.5.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2017-2022)
2.5.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Home Insulin Delivery (Dosing) Devices Sales by Manufacturers
3.1.1 Global Top Home Insulin Delivery (Dosing) Devices Manufacturers by Sales (2017-2022)
3.1.2 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Home Insulin Delivery (Dosing) Devices in 2021
3.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Manufacturers
3.2.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Manufacturers (2017-2022)
3.2.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Home Insulin Delivery (Dosing) Devices Revenue in 2021
3.3 Global Home Insulin Delivery (Dosing) Devices Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Home Insulin Delivery (Dosing) Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Home Insulin Delivery (Dosing) Devices Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Home Insulin Delivery (Dosing) Devices Sales by Type
4.1.1 Global Home Insulin Delivery (Dosing) Devices Historical Sales by Type (2017-2022)
4.1.2 Global Home Insulin Delivery (Dosing) Devices Forecasted Sales by Type (2023-2028)
4.1.3 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2028)
4.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Type
4.2.1 Global Home Insulin Delivery (Dosing) Devices Historical Revenue by Type (2017-2022)
4.2.2 Global Home Insulin Delivery (Dosing) Devices Forecasted Revenue by Type (2023-2028)
4.2.3 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2017-2028)
4.3 Global Home Insulin Delivery (Dosing) Devices Price by Type
4.3.1 Global Home Insulin Delivery (Dosing) Devices Price by Type (2017-2022)
4.3.2 Global Home Insulin Delivery (Dosing) Devices Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Home Insulin Delivery (Dosing) Devices Sales by Application
5.1.1 Global Home Insulin Delivery (Dosing) Devices Historical Sales by Application (2017-2022)
5.1.2 Global Home Insulin Delivery (Dosing) Devices Forecasted Sales by Application (2023-2028)
5.1.3 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2028)
5.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Application
5.2.1 Global Home Insulin Delivery (Dosing) Devices Historical Revenue by Application (2017-2022)
5.2.2 Global Home Insulin Delivery (Dosing) Devices Forecasted Revenue by Application (2023-2028)
5.2.3 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2017-2028)
5.3 Global Home Insulin Delivery (Dosing) Devices Price by Application
5.3.1 Global Home Insulin Delivery (Dosing) Devices Price by Application (2017-2022)
5.3.2 Global Home Insulin Delivery (Dosing) Devices Price Forecast by Application (2023-2028)
6 North America
6.1 North America Home Insulin Delivery (Dosing) Devices Market Size by Type
6.1.1 North America Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2028)
6.1.2 North America Home Insulin Delivery (Dosing) Devices Revenue by Type (2017-2028)
6.2 North America Home Insulin Delivery (Dosing) Devices Market Size by Application
6.2.1 North America Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2028)
6.2.2 North America Home Insulin Delivery (Dosing) Devices Revenue by Application (2017-2028)
6.3 North America Home Insulin Delivery (Dosing) Devices Market Size by Country
6.3.1 North America Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2028)
6.3.2 North America Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Home Insulin Delivery (Dosing) Devices Market Size by Type
7.1.1 Europe Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2028)
7.1.2 Europe Home Insulin Delivery (Dosing) Devices Revenue by Type (2017-2028)
7.2 Europe Home Insulin Delivery (Dosing) Devices Market Size by Application
7.2.1 Europe Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2028)
7.2.2 Europe Home Insulin Delivery (Dosing) Devices Revenue by Application (2017-2028)
7.3 Europe Home Insulin Delivery (Dosing) Devices Market Size by Country
7.3.1 Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2028)
7.3.2 Europe Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Home Insulin Delivery (Dosing) Devices Market Size by Type
8.1.1 Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2028)
8.1.2 Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Type (2017-2028)
8.2 Asia Pacific Home Insulin Delivery (Dosing) Devices Market Size by Application
8.2.1 Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2028)
8.2.2 Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Application (2017-2028)
8.3 Asia Pacific Home Insulin Delivery (Dosing) Devices Market Size by Region
8.3.1 Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Region (2017-2028)
8.3.2 Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Home Insulin Delivery (Dosing) Devices Market Size by Type
9.1.1 Latin America Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2028)
9.1.2 Latin America Home Insulin Delivery (Dosing) Devices Revenue by Type (2017-2028)
9.2 Latin America Home Insulin Delivery (Dosing) Devices Market Size by Application
9.2.1 Latin America Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2028)
9.2.2 Latin America Home Insulin Delivery (Dosing) Devices Revenue by Application (2017-2028)
9.3 Latin America Home Insulin Delivery (Dosing) Devices Market Size by Country
9.3.1 Latin America Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2028)
9.3.2 Latin America Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Size by Type
10.1.1 Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2028)
10.1.2 Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Type (2017-2028)
10.2 Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Size by Application
10.2.1 Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2028)
10.2.2 Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Application (2017-2028)
10.3 Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Size by Country
10.3.1 Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2028)
10.3.2 Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Tandem Diabetes Care
11.1.1 Tandem Diabetes Care Corporation Information
11.1.2 Tandem Diabetes Care Overview
11.1.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Tandem Diabetes Care Recent Developments
11.2 Biocon
11.2.1 Biocon Corporation Information
11.2.2 Biocon Overview
11.2.3 Biocon Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Biocon Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biocon Recent Developments
11.3 Roche Holding AG
11.3.1 Roche Holding AG Corporation Information
11.3.2 Roche Holding AG Overview
11.3.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Holding AG Recent Developments
11.4 Insulet Corporation
11.4.1 Insulet Corporation Corporation Information
11.4.2 Insulet Corporation Overview
11.4.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Insulet Corporation Recent Developments
11.5 B. Braun
11.5.1 B. Braun Corporation Information
11.5.2 B. Braun Overview
11.5.3 B. Braun Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 B. Braun Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 B. Braun Recent Developments
11.6 BD
11.6.1 BD Corporation Information
11.6.2 BD Overview
11.6.3 BD Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 BD Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BD Recent Developments
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Corporation Information
11.7.2 Eli Lilly and Company Overview
11.7.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Eli Lilly and Company Recent Developments
11.8 Novo Nordisk
11.8.1 Novo Nordisk Corporation Information
11.8.2 Novo Nordisk Overview
11.8.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novo Nordisk Recent Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Overview
11.9.3 Sanofi Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sanofi Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Recent Developments
11.10 Wockhardt
11.10.1 Wockhardt Corporation Information
11.10.2 Wockhardt Overview
11.10.3 Wockhardt Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Wockhardt Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Wockhardt Recent Developments
11.11 Ypsomed Holding
11.11.1 Ypsomed Holding Corporation Information
11.11.2 Ypsomed Holding Overview
11.11.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Ypsomed Holding Recent Developments
11.12 Medtronic
11.12.1 Medtronic Corporation Information
11.12.2 Medtronic Overview
11.12.3 Medtronic Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Medtronic Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Medtronic Recent Developments
11.13 Julphar
11.13.1 Julphar Corporation Information
11.13.2 Julphar Overview
11.13.3 Julphar Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Julphar Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Julphar Recent Developments
11.14 Beta Bionics
11.14.1 Beta Bionics Corporation Information
11.14.2 Beta Bionics Overview
11.14.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Beta Bionics Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Beta Bionics Recent Developments
11.15 Copernicus
11.15.1 Copernicus Corporation Information
11.15.2 Copernicus Overview
11.15.3 Copernicus Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Copernicus Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Copernicus Recent Developments
11.16 Dance Biopharm
11.16.1 Dance Biopharm Corporation Information
11.16.2 Dance Biopharm Overview
11.16.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Dance Biopharm Recent Developments
11.17 Debiotech
11.17.1 Debiotech Corporation Information
11.17.2 Debiotech Overview
11.17.3 Debiotech Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Debiotech Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Debiotech Recent Developments
11.18 MannKind
11.18.1 MannKind Corporation Information
11.18.2 MannKind Overview
11.18.3 MannKind Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 MannKind Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 MannKind Recent Developments
11.19 Owen Mumford
11.19.1 Owen Mumford Corporation Information
11.19.2 Owen Mumford Overview
11.19.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Owen Mumford Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Owen Mumford Recent Developments
11.20 SOOIL
11.20.1 SOOIL Corporation Information
11.20.2 SOOIL Overview
11.20.3 SOOIL Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 SOOIL Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 SOOIL Recent Developments
11.21 Valeritas
11.21.1 Valeritas Corporation Information
11.21.2 Valeritas Overview
11.21.3 Valeritas Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Valeritas Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Valeritas Recent Developments
11.22 West Pharma
11.22.1 West Pharma Corporation Information
11.22.2 West Pharma Overview
11.22.3 West Pharma Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 West Pharma Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 West Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Home Insulin Delivery (Dosing) Devices Industry Chain Analysis
12.2 Home Insulin Delivery (Dosing) Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Home Insulin Delivery (Dosing) Devices Production Mode & Process
12.4 Home Insulin Delivery (Dosing) Devices Sales and Marketing
12.4.1 Home Insulin Delivery (Dosing) Devices Sales Channels
12.4.2 Home Insulin Delivery (Dosing) Devices Distributors
12.5 Home Insulin Delivery (Dosing) Devices Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Home Insulin Delivery (Dosing) Devices Industry Trends
13.2 Home Insulin Delivery (Dosing) Devices Market Drivers
13.3 Home Insulin Delivery (Dosing) Devices Market Challenges
13.4 Home Insulin Delivery (Dosing) Devices Market Restraints
14 Key Findings in The Global Home Insulin Delivery (Dosing) Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Home Insulin Delivery (Dosing) Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Insulin Pens
Table 3. Major Manufacturers of Insulin Pumps
Table 4. Major Manufacturers of Insulin Syringes
Table 5. Major Manufacturers of Others
Table 6. Global Home Insulin Delivery (Dosing) Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Home Insulin Delivery (Dosing) Devices Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Home Insulin Delivery (Dosing) Devices Sales by Region (2017-2022) & (K Units)
Table 9. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2017-2022)
Table 10. Global Home Insulin Delivery (Dosing) Devices Sales by Region (2023-2028) & (K Units)
Table 11. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2023-2028)
Table 12. Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2017-2022)
Table 14. Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2023-2028)
Table 16. Global Home Insulin Delivery (Dosing) Devices Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Home Insulin Delivery (Dosing) Devices Sales Share by Manufacturers (2017-2022)
Table 18. Global Home Insulin Delivery (Dosing) Devices Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Home Insulin Delivery (Dosing) Devices Revenue Share by Manufacturers (2017-2022)
Table 20. Home Insulin Delivery (Dosing) Devices Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Home Insulin Delivery (Dosing) Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Home Insulin Delivery (Dosing) Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Home Insulin Delivery (Dosing) Devices as of 2021)
Table 23. Home Insulin Delivery (Dosing) Devices Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Home Insulin Delivery (Dosing) Devices Product Offered
Table 25. Date of Manufacturers Enter into Home Insulin Delivery (Dosing) Devices Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2022) & (K Units)
Table 28. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2023-2028) & (K Units)
Table 29. Global Home Insulin Delivery (Dosing) Devices Sales Share by Type (2017-2022)
Table 30. Global Home Insulin Delivery (Dosing) Devices Sales Share by Type (2023-2028)
Table 31. Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Home Insulin Delivery (Dosing) Devices Revenue Share by Type (2017-2022)
Table 34. Global Home Insulin Delivery (Dosing) Devices Revenue Share by Type (2023-2028)
Table 35. Home Insulin Delivery (Dosing) Devices Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Home Insulin Delivery (Dosing) Devices Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2022) & (K Units)
Table 38. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2023-2028) & (K Units)
Table 39. Global Home Insulin Delivery (Dosing) Devices Sales Share by Application (2017-2022)
Table 40. Global Home Insulin Delivery (Dosing) Devices Sales Share by Application (2023-2028)
Table 41. Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Home Insulin Delivery (Dosing) Devices Revenue Share by Application (2017-2022)
Table 44. Global Home Insulin Delivery (Dosing) Devices Revenue Share by Application (2023-2028)
Table 45. Home Insulin Delivery (Dosing) Devices Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Home Insulin Delivery (Dosing) Devices Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2022) & (K Units)
Table 48. North America Home Insulin Delivery (Dosing) Devices Sales by Type (2023-2028) & (K Units)
Table 49. North America Home Insulin Delivery (Dosing) Devices Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Home Insulin Delivery (Dosing) Devices Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2022) & (K Units)
Table 52. North America Home Insulin Delivery (Dosing) Devices Sales by Application (2023-2028) & (K Units)
Table 53. North America Home Insulin Delivery (Dosing) Devices Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Home Insulin Delivery (Dosing) Devices Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) & (K Units)
Table 56. North America Home Insulin Delivery (Dosing) Devices Sales by Country (2023-2028) & (K Units)
Table 57. North America Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Home Insulin Delivery (Dosing) Devices Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2022) & (K Units)
Table 60. Europe Home Insulin Delivery (Dosing) Devices Sales by Type (2023-2028) & (K Units)
Table 61. Europe Home Insulin Delivery (Dosing) Devices Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Home Insulin Delivery (Dosing) Devices Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2022) & (K Units)
Table 64. Europe Home Insulin Delivery (Dosing) Devices Sales by Application (2023-2028) & (K Units)
Table 65. Europe Home Insulin Delivery (Dosing) Devices Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Home Insulin Delivery (Dosing) Devices Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) & (K Units)
Table 68. Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2023-2028) & (K Units)
Table 69. Europe Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Home Insulin Delivery (Dosing) Devices Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Home Insulin Delivery (Dosing) Devices Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Home Insulin Delivery (Dosing) Devices Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Home Insulin Delivery (Dosing) Devices Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Home Insulin Delivery (Dosing) Devices Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Home Insulin Delivery (Dosing) Devices Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Home Insulin Delivery (Dosing) Devices Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Home Insulin Delivery (Dosing) Devices Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Home Insulin Delivery (Dosing) Devices Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Country (2023-2028) & (US$ Million)
Table 107. Tandem Diabetes Care Corporation Information
Table 108. Tandem Diabetes Care Description and Major Businesses
Table 109. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Tandem Diabetes Care Recent Developments
Table 112. Biocon Corporation Information
Table 113. Biocon Description and Major Businesses
Table 114. Biocon Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Biocon Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Biocon Recent Developments
Table 117. Roche Holding AG Corporation Information
Table 118. Roche Holding AG Description and Major Businesses
Table 119. Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Roche Holding AG Recent Developments
Table 122. Insulet Corporation Corporation Information
Table 123. Insulet Corporation Description and Major Businesses
Table 124. Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Insulet Corporation Recent Developments
Table 127. B. Braun Corporation Information
Table 128. B. Braun Description and Major Businesses
Table 129. B. Braun Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. B. Braun Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. B. Braun Recent Developments
Table 132. BD Corporation Information
Table 133. BD Description and Major Businesses
Table 134. BD Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. BD Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. BD Recent Developments
Table 137. Eli Lilly and Company Corporation Information
Table 138. Eli Lilly and Company Description and Major Businesses
Table 139. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Eli Lilly and Company Recent Developments
Table 142. Novo Nordisk Corporation Information
Table 143. Novo Nordisk Description and Major Businesses
Table 144. Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Novo Nordisk Recent Developments
Table 147. Sanofi Corporation Information
Table 148. Sanofi Description and Major Businesses
Table 149. Sanofi Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Sanofi Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Sanofi Recent Developments
Table 152. Wockhardt Corporation Information
Table 153. Wockhardt Description and Major Businesses
Table 154. Wockhardt Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Wockhardt Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Wockhardt Recent Developments
Table 157. Ypsomed Holding Corporation Information
Table 158. Ypsomed Holding Description and Major Businesses
Table 159. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Ypsomed Holding Recent Developments
Table 162. Medtronic Corporation Information
Table 163. Medtronic Description and Major Businesses
Table 164. Medtronic Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. Medtronic Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Medtronic Recent Developments
Table 167. Julphar Corporation Information
Table 168. Julphar Description and Major Businesses
Table 169. Julphar Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 170. Julphar Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Julphar Recent Developments
Table 172. Beta Bionics Corporation Information
Table 173. Beta Bionics Description and Major Businesses
Table 174. Beta Bionics Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 175. Beta Bionics Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Beta Bionics Recent Developments
Table 177. Copernicus Corporation Information
Table 178. Copernicus Description and Major Businesses
Table 179. Copernicus Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 180. Copernicus Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Copernicus Recent Developments
Table 182. Dance Biopharm Corporation Information
Table 183. Dance Biopharm Description and Major Businesses
Table 184. Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 185. Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Dance Biopharm Recent Developments
Table 187. Debiotech Corporation Information
Table 188. Debiotech Description and Major Businesses
Table 189. Debiotech Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 190. Debiotech Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Debiotech Recent Developments
Table 192. MannKind Corporation Information
Table 193. MannKind Description and Major Businesses
Table 194. MannKind Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 195. MannKind Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. MannKind Recent Developments
Table 197. Owen Mumford Corporation Information
Table 198. Owen Mumford Description and Major Businesses
Table 199. Owen Mumford Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 200. Owen Mumford Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Owen Mumford Recent Developments
Table 202. SOOIL Corporation Information
Table 203. SOOIL Description and Major Businesses
Table 204. SOOIL Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 205. SOOIL Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. SOOIL Recent Developments
Table 207. Valeritas Corporation Information
Table 208. Valeritas Description and Major Businesses
Table 209. Valeritas Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 210. Valeritas Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 211. Valeritas Recent Developments
Table 212. West Pharma Corporation Information
Table 213. West Pharma Description and Major Businesses
Table 214. West Pharma Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 215. West Pharma Home Insulin Delivery (Dosing) Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 216. West Pharma Recent Developments
Table 217. Key Raw Materials Lists
Table 218. Raw Materials Key Suppliers Lists
Table 219. Home Insulin Delivery (Dosing) Devices Distributors List
Table 220. Home Insulin Delivery (Dosing) Devices Customers List
Table 221. Home Insulin Delivery (Dosing) Devices Market Trends
Table 222. Home Insulin Delivery (Dosing) Devices Market Drivers
Table 223. Home Insulin Delivery (Dosing) Devices Market Challenges
Table 224. Home Insulin Delivery (Dosing) Devices Market Restraints
Table 225. Research Programs/Design for This Report
Table 226. Key Data Information from Secondary Sources
Table 227. Key Data Information from Primary Sources
List of Figures
Figure 1. Home Insulin Delivery (Dosing) Devices Product Picture
Figure 3. Global Home Insulin Delivery (Dosing) Devices Market Share by Type in 2021 & 2028
Figure 3. Insulin Pens Product Picture
Figure 4. Insulin Pumps Product Picture
Figure 5. Insulin Syringes Product Picture
Figure 6. Others Product Picture
Figure 7. Global Home Insulin Delivery (Dosing) Devices Market Share by Application in 2021 & 2028
Figure 8. Hospitals Pharmacy
Figure 9. Online Pharmacy
Figure 10. Retail Pharmacy
Figure 11. Home Insulin Delivery (Dosing) Devices Report Years Considered
Figure 12. Global Home Insulin Delivery (Dosing) Devices Sales 2017-2028 (K Units)
Figure 13. Global Home Insulin Delivery (Dosing) Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Home Insulin Delivery (Dosing) Devices Revenue 2017-2028 (US$ Million)
Figure 15. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2017-2022)
Figure 17. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2023-2028)
Figure 18. North America Home Insulin Delivery (Dosing) Devices Sales YoY (2017-2028) & (K Units)
Figure 19. North America Home Insulin Delivery (Dosing) Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Home Insulin Delivery (Dosing) Devices Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Home Insulin Delivery (Dosing) Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Home Insulin Delivery (Dosing) Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Home Insulin Delivery (Dosing) Devices Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Home Insulin Delivery (Dosing) Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Home Insulin Delivery (Dosing) Devices Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Home Insulin Delivery (Dosing) Devices in the World: Market Share by Home Insulin Delivery (Dosing) Devices Revenue in 2021
Figure 30. Global Home Insulin Delivery (Dosing) Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2028)
Figure 32. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2017-2028)
Figure 33. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2028)
Figure 34. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2017-2028)
Figure 35. North America Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2028)
Figure 36. North America Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2017-2028)
Figure 37. North America Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2028)
Figure 38. North America Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2017-2028)
Figure 39. North America Home Insulin Delivery (Dosing) Devices Sales Share by Country (2017-2028)
Figure 40. North America Home Insulin Delivery (Dosing) Devices Revenue Share by Country (2017-2028)
Figure 41. United States Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2028)
Figure 44. Europe Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2017-2028)
Figure 45. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2028)
Figure 46. Europe Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2017-2028)
Figure 47. Europe Home Insulin Delivery (Dosing) Devices Sales Share by Country (2017-2028)
Figure 48. Europe Home Insulin Delivery (Dosing) Devices Revenue Share by Country (2017-2028)
Figure 49. Germany Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 50. France Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue Share by Region (2017-2028)
Figure 60. China Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 63. India Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2028)
Figure 70. Latin America Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2028)
Figure 72. Latin America Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Home Insulin Delivery (Dosing) Devices Sales Share by Country (2017-2028)
Figure 74. Latin America Home Insulin Delivery (Dosing) Devices Revenue Share by Country (2017-2028)
Figure 75. Mexico Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 78. Colombia Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue Share by Country (2017-2028)
Figure 85. Turkey Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Home Insulin Delivery (Dosing) Devices Revenue (2017-2028) & (US$ Million)
Figure 88. Home Insulin Delivery (Dosing) Devices Value Chain
Figure 89. Home Insulin Delivery (Dosing) Devices Production Process
Figure 90. Channels of Distribution
Figure 91

★調査レポート[家庭用インスリンデリバリー（投薬）装置の世界市場インサイト・予測（～2028年）] (コード：QY22JLX09543)販売に関する免責事項を必ずご確認ください。
★調査レポート[家庭用インスリンデリバリー（投薬）装置の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 勃起不全（ED）装置の世界市場インサイト・予測（～2028年）
  • 泌尿器科インプラント・装置の世界市場インサイト・予測（～2028年）
  • 気道陽圧（PAP）装置の世界市場インサイト・予測（～2028年）
  • 農業用可変作業技術 (VRT) 装置の世界市場インサイト・予測（～2028年）
  • 末期腎疾患（ESRD）装置の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆